Skip navigation

Pharmaphorum: Artificial intelligence in drug discovery and diagnosis

“We are turning the drug-discovery paradigm upside down by using patient-driven biology and data to derive more predictive hypotheses, rather than the traditional trial-and-error approach,” said Niven Narain, PhD., BERG’s Co-founder, President and CEO.

To read the full article, click here.